Associate Professor, Medicine, University of Minnesota Medical School, Minneapolis
Nephrology
Dr. Ajay K. Israni, MD
|
|
Give Review
Ajay Israni works in the field of Nephrology. He attended NYU School of Medicine. He over the years received 1 awards: "CMS Meaningful Use Stage 1 Certification". Ajay K. Israni, MD is a published doctor. He has 88 papers published. The most current publication "Clostridium septicum endocarditis complicated by aortic-ring abscess and aortitis."
Publications
- Allocating Deceased Donor Kidneys to Candidates with High Panel-Reactive Antibodies.
- Developing Statistical Models to Assess Transplant Outcomes Using National Registries: The Process in the United States.
- Genomewide Association Study of Tacrolimus Concentrations in African American Kidney Transplant Recipients Identifies Multiple CYP3A5 Alleles.
- Impact of increased time at the highest urgency category on heart transplant outcomes for candidates With ventricular assist devices.
- A Prospective Controlled Study of Living Kidney Donors: Three-Year Follow-up.
- OPTN/SRTR 2013 Annual Data Report: intestine.
- OPTN/SRTR 2013 Annual Data Report: deceased organ donation.
- OPTN/SRTR 2013 Annual Data Report: Heart.
- OPTN/SRTR 2013 Annual Data Report: Kidney.
- OPTN/SRTR 2013 Annual Data Report: pancreas.
- Designing systematic and center-specific metrics to foster innovation.
- Accept/decline decision module for the liver simulated allocation model.
- Variation in Structure and Delivery of Care Between Kidney Transplant Centers in the United States.
- New National Allocation Policy for Deceased Donor Kidneys in the United States and Possible Effect on Patient Outcomes.
- The Role of Procurement Biopsies in Acceptance Decisions for Kidneys Retrieved for Transplant.
- Telomere length of recipients and living Kidney donors and chronic graft dysfunction in Kidney transplants.
- OPTN/SRTR 2012 Annual Data Report: Heart.
- OPTN/SRTR 2012 Annual Data Report: Lung.
- OPTN/SRTR 2012 Annual Data Report: Deceased Organ Donation.
- The equitable allocation of deceased donor lungs for transplant in children in the United States.
- OPTN/SRTR 2012 Annual Data Report: Kidney.
- OPTN/SRTR 2012 Annual Data Report: Pancreas.
- OPTN/SRTR 2012 Annual Data Report: Intestine.
- The Kidney allocation system.
- Tacrolimus trough levels after month 3 as a predictor of Acute rejection following kidney transplantation: a lesson learned from DeKAF Genomics.
- Predicting End-Stage Renal Disease After Liver Transplant.
- Scientific Registry of Transplant Recipients: Collecting, analyzing, and reporting data on transplantation in the United States.
- Regional variability in liver waiting list removals causes false ascertainment of waiting list deaths.
- Optimizing the program-specific reporting of pancreas transplant outcomes.
- Inflammation in the setting of chronic allograft dysfunction post-Kidney transplant: phenotype and genotype.
- OPTN/SRTR 2011 Annual Data Report: Kidney.
- OPTN/SRTR 2011 Annual Data Report: pancreas.
- OPTN/SRTR 2011 Annual Data Report: liver.
- OPTN/SRTR 2011 Annual Data Report: intestine.
- OPTN/SRTR 2011 Annual Data Report: Heart.
- OPTN/SRTR 2011 Annual Data Report: lung.
- OPTN/SRTR 2011 Annual Data Report: deceased organ donation.
- OPTN/SRTR 2011 Annual Data Report: international data.
- Lung and Heart Allocation in the United States.
- Kidney, pancreas and liver allocation and distribution in the United States.
- Donor polymorphisms of TLR4 associated with graft Failure in liver transplant recipients.
- Lower Calcineurin Inhibitor Doses in Older Compared to Younger Kidney Transplant Recipients Yield Similar Troughs.
- Clinical diagnosis of metabolic syndrome: predicting new-onset diabetes, coronary heart disease, and allograft failure late after Kidney transplant.
- Spectrum of cancer risk among US solid organ transplant recipients.
- Lymphoproliferative Disorders After Adult Kidney Transplant: Epidemiology and Comparison of Registry Report With Claims-Based Diagnoses.
- Dosing Equation for Tacrolimus Using Genetic Variants and Clinical Factors.
- Cardiovascular Disease medications after renal transplantation: results from the Patient Outcomes in Renal Transplantation study.
- Donor exchange programs in Kidney transplantation: rationale and operational details from the north central donor exchange cooperative.
- Kidney transplant patients' perceptions, beliefs, and barriers related to regular nephrology outpatient visits.
- A simple tool to predict outcomes after Kidney transplant.
- "Nature versus nurture" study of deceased-donor pairs in Kidney transplantation.
- Best option for transplant candidates with type 1 diabetes and a live Kidney donor: a bird in the hand is worth two in the bush.
- Rates of first infection following Kidney transplant in the United States.
- HLA-A amino acid polymorphism and delayed Kidney allograft function.
- Association of donor inflammation- and apoptosis-related genotypes and delayed allograft function after Kidney transplantation.
- Association of hypertension genotypes and decline in renal function after Kidney transplantation.
- Hepatitis C virus seropositivity in organ donors and survival in heart transplant recipients.
- Race and electronically measured adherence to immunosuppressive medications after deceased donor Renal transplantation.
- Willingness of patients to switch from conventional to daily hemodialysis: looking before we leap.
- Willingness of dialysis patients to participate in a randomized controlled trial of daily dialysis.
- Metformin use in Kidney transplant recipients in the United States: an observational study.
- The geography of Kidney transplantation in the United States.
- Assessment of differences in HLA-A, -B, and -DRB1 allele mismatches among African-American and non-African-American recipients of deceased Kidney transplants.
- Effect of comorbidity adjustment on CMS criteria for Kidney transplant center performance.
- Incentive models to increase living Kidney donation: encouraging without coercing.
- Impact of simultaneous Kidney-pancreas transplant and timing of transplant on Kidney allograft survival.
- Ganciclovir prophylaxis delays but does not prevent cytomegalovirus infection in Renal transplant recipients.
- Somatic mosaicism for a newly identified splice-site mutation in a patient With adenosine deaminase-deficient immunodeficiency and spontaneous clinical recovery.
- An Asp8Asn substitution results in the adenosine deaminase (ADA) genetic polymorphism (ADA 2 allozyme): occurrence on different chromosomal backgrounds and apparent in...
- Two new mutations at the adenosine deaminase (ADA) locus (Q254X and del nt1050-54) unusual for not being missense mutations.
- Clostridium septicum endocarditis complicated by aortic-ring abscess and aortitis.
- Quality of life after transplantation for patients with Diabetes and renal dysfunction.
- Design considerations and feasibility for a clinical trial to examine coronary screening before Kidney transplantation (COST).
- The relationship between Kidney function and long-term graft survival after Kidney transplant.
- Transporting live donor Kidneys for Kidney paired donation: initial national results.
- Electronically measured adherence to immunosuppressive medications and Kidney function after deceased donor Kidney transplantation.
- Similar outcomes With different rates of delayed graft function may reflect center practice, not center performance.
- Who is caring for Kidney transplant patients? Variation by region, transplant center, and patient characteristics.
- Predicting coronary heart disease after Kidney transplantation: Patient Outcomes in Renal Transplantation (PORT) Study.
- Single-nucleotide polymorphisms, Acute rejection, and severity of tubulitis in kidney transplantation, accounting for center-to-center variation.
- Genetic determinants of mycophenolate-related anemia and leukopenia after transplantation.
- Novel polymorphisms associated with tacrolimus trough concentrations: results from a multicenter Kidney transplant consortium.
- Validation of single nucleotide polymorphisms associated with Acute rejection in kidney transplant recipients using a large multi-center cohort.
- Conversion to tacrolimus for the treatment of cyclosporine-associated nephrotoxicity in Heart transplant recipients.
- Management of chronic Kidney disease in an academic primary care clinic.
- Religiosity in a hemodialysis population and its relationship to satisfaction With medical care, satisfaction With life, and adherence.
- A comparison of four feature selection algorithms applied to multiply-imputed proteomic data.
Schools
New York University
University Penn School Med
Procedures Preformed
- Arteriovenostomy for Renal Dialysis
- Hemodialysis
- Peritoneal Dialysis
Conditions Treated
- Acidosis
- Acute Kidney Failure
- Alkalosis
- Calcium Metabolism Disorders
- View All
Doctors Specialties
- Nephrology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
University of Pennsylvania Health System -
Boston University Medical Center -
NYU School of Medicine
Hospital
-
Hennepin County Medical Center
Drug Facts
| NPI NUMBER | 1447205729 | |
| NPPES Provider LastName | ISRANI | |
| NPPES Provider FirstName | AJAY | |
| NPPES Provider ZIPCode | 554151623 | |
| NPPES Provider State | MN | |
| Specialty Description | Nephrology | |
| Total Claim Count | 1624.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1447205729 |
| Last Name Of The Provider | ISRANI |
| First Name Of The Provider | AJAY |
| View All |
Similar Doctors
|
|
Dr. Alec D. Otteman, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alan J. Collins, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Allyson Hart, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. King W. Ma, MD |
|
|
Dr. John R. Silkensen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Henry T. Smith, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sameea Sadiq, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. George T. O'Bryan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Edward Muter, MD |
|
|
Robert N. Foley, MB |